Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589

By Johnson Fred L.   Boyer José L.   Leese Philip T.   Crean Christopher   Krishnamoorthy Ramesh   Durham Todd   Fox Anthony W.   Kellerman Donald J.  

Platelets, Vol. 18, Iss. 5, 2007-08 ,pp. : 346-356

Informa Healthcare

Access to resources Recommend Favorite

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

By Klinkhardt U.   Kuczka K.   Harder S.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 251-257

Elsevier

Access to resources Recommend Favorite

Prasugrel, a Platelet P2Y₁₂ Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP

By Iyú David   Glenn Jackie R.   White Ann E.   Fox Sue C.   Dovlatova Natalia   Heptinstall Stan  

Platelets, Vol. 22, Iss. 7, 2011-11 ,pp. : 504-515

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y₁ and P2Y₁₂ receptor antagonists on platelet aggregation induced by different agonists in human whole blood

By Storey Robert F.   Newby Linda J.   Heptinstall Stan  

Platelets, Vol. 12, Iss. 7, 2001-11 ,pp. : 443-447

Informa Healthcare

Access to resources Recommend Favorite